NMPA approves CSPC Pharma's dupilumab injection to clinical trials (HK$10.64, 0.00)
StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (54 total)
StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (170 total)
StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (37 total)
StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (166 total)
StreetAccount Summary: Hong Kong Stocks reaching new 52-week highs/lows (45 total)
StreetAccount Summary: Asian stocks reaching new 52-week highs/lows (118 total)
CSPC Pharmaceutical Group initiated buy at TF Securities (HK$10.36, 0.00)
StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning
StreetAccount Summary - Trading higher/lower: Asia mid-morning
Powered by FactSet Research Systems Inc.